+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

S

Actively Recruiting

Researchers are evaluating the efficacy and safety of Qishen Yiqi Dripping Pills in treating Chronic Heart Failure with reduced ejection fraction caused by Coronary Heart Disease, specifically in patients with Syndrome of Qi Deficiency with Blood Stasis. This phase 3 randomized controlled trial aims to provide evidence on this traditional Chinese medicine treatment for heart failure. Participants will be randomly assigned to receive either Qishen Yiqi Dripping Pills or a placebo. The treatment involves taking 2 bags of the pills orally, three times a day, half an hour after meals, over a 12-week period. The study uses a quadruple masking design to compare the effects of the active treatment with placebo. During the 12 weeks of treatment, participants will undergo various assessments including the 6-minute walk test, quality of life questionnaires, symptom tracking, echocardiographic measurements, and blood tests for heart function biomarkers at baseline and at weeks 4, 8, and 12. Researchers will monitor exercise capacity, heart failure symptoms, cardiac function, and safety throughout the study to understand the treatments impact and tolerability.

Age: 18Years - 80YearsAll GendersPhase 3
60 locations